CoChat

The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires

Bergmann, Tobias, Moore, Carrie, Sidney, John, Miller, Donald, Tallmadge, Rebecca, Harman, Rebecca M., Oseroff, Carla, Wriston, Amanda, Shabanowitz, Jeffrey, Hunt, Donald F., Osterrieder, Nikolaus, Peters, Bjoern, Antczak, Douglas F., Sette, Alessandro · 2015 · Immunogenetics
Cited by 7

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00251-015-0872-z

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 76

  1. Albrecht RA, Jang HK, Kim SK, O’Callaghan DJ (2003) Direct interaction of TFIIB and the IE protein of equine herpesvirus 1 is required for maximal trans-activation function. Virology 316:302–12 · doi:10.1016/j.virol.2003.08.017
  2. Allen G, Yeargan M, Costa LR, Cross R (1995) Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J Virol 69:606–12 · DOI · Paper page
  3. Allen GP, Kydd JH, Slater JD, Smith KC (2004) Equid herpesvirus 1 and equid herpesvirus 4 infections. In: Coetzer JAW, Tustin RC (eds) Infectious diseases of livestock. Oxford University Press, Newmarket
  4. Ambagala AP, Gopinath RS, Srikumaran S (2004) Peptide transport activity of the transporter associated with antigen processing (TAP) is inhibited by an early protein of equine herpesvirus-1. J Gen Virol 85:349–53 · DOI · Paper page
  5. Antczak DF, Bailey E, Barger B, Guerin G, Lazary S, McClure J, Mottironi VD, Symons R, Templeton J, Varewyck H (1986) Joint report of the Third International Workshop on Lymphocyte alloantigens of the horse, Kennett Square, Pennsylvania, 25–27 April 1984. Anim Genet 17:363–73 · doi:10.1111/j.1365-2052.1986.tb00730.x
  6. Antczak DF, Bright SM, Remick LH, Bauman BE (1982) Lymphocyte alloantigens of the horse. I. Serologic and genetic studies. Tissue Antigens 20:172–87 · doi:10.1111/j.1399-0039.1982.tb00343.x
  7. Assarsson E, Sidney J, Oseroff C, Pasquetto V, Bui H-H, Frahm N, Brander C, Peters B, Grey H, Sette A (2007) A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J Immunol 178:7890–7901 · DOI · Paper page
  8. Azab W, Harman R, Miller D, Tallmadge R, Frampton AR Jr, Antczak DF, Osterrieder N (2014) Equid herpesvirus type 4 uses a restricted set of equine major histocompatibility complex class I proteins as entry receptors. J Gen Virol 95:1554–63 · DOI
  9. Bailey E, Marti E, Fraxer DG, Antczak DF, Lazary S (2000) Immunogenetics of the horse. In: Bowling AT, Ruvinski A (eds) The genetics of the horse. CABI, Wallingford, UK
  10. Bairoch A, Apweiler R (2000) The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res 28:45–8 · DOI · Paper page
  11. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–108 · DOI · Paper page
  12. Derbigny WA, Kim SK, Caughman GB, O’Callaghan DJ (2000) The EICP22 protein of equine herpesvirus 1 physically interacts with the immediate-early protein and with itself to form dimers and higher-order complexes. J Virol 74:1425–35 · DOI
  13. Doll ER, Crowe ME, Bryans JT, Mc CW (1955) Infection immunity in equine virus abortion. Cornell Vet 45:387–410
  14. Earley L, Anderson LC, Bai DL, Mullen C, Syka JE, English AM, Dunyach JJ, Stafford GC Jr, Shabanowitz J, Hunt DF, Compton PD (2013) Front-end electron transfer dissociation: a new ionization source. Anal Chem 85:8385–90 · DOI · Paper page
  15. Gaddum RM, Ellis SA, Willis AC, Cook RS, Staines KA, Thomas LH, Taylor G (1996) Identification of potential CTL epitopes of bovine RSV using allele-specific peptide motifs from bovine MHC class I molecules. Vet Immunol Immunopathol 54:211–9 · DOI
  16. Geer LY, Markey SP, Kowalak JA, Wagner L, Xu M, Maynard DM, Yang X, Shi W, Bryant SH (2004) Open mass spectrometry search algorithm. J Proteome Res 3:958–64 · DOI · Paper page
  17. Germain RN, Margulies DH (1993) The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11:403–50 · doi:10.1146/annurev.iy.11.040193.002155 · Paper page
  18. Gillet L, May JS, Colaco S, Stevenson PG (2007) The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization. PLoS ONE 2:e705 · DOI
  19. Gubler B, Daniel S, Armandola EA, Hammer J, Caillat-Zucman S, van Endert PM (1998) Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP. Mol Immunol 35:427–33 · DOI
  20. Gulukota K, Sidney J, Sette A, DeLisi C (1997) Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J Mol Biol 267:1258–67 · DOI · Paper page
  21. Gustafson AL, Tallmadge RL, Ramlachan N, Miller D, Bird H, Antczak DF, Raudsepp T, Chowdhary BP, Skow LC (2003) An ordered BAC contig map of the equine major histocompatibility complex. Cytogenet Genome Res 102:189–95 · DOI
  22. Guzman E, Taylor G, Charleston B, Ellis SA (2010) Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination. J Virol 84:12375–84 · doi:10.1128/jvi.01545-10
  23. Hagen J, Hartnett C, Houchins JP, Giguere S, Kalyuzhny AE (2012) Equine ELISPOT assay to study secretion of IFNgamma and IL-4 from peripheral blood mononuclear cells. Methods Mol Biol 792:39–45 · doi:10.1007/978-1-61779-325-7_3
  24. Hannant D, Jessett DM, O’Neill T, Dolby CA, Cook RF, Mumford JA (1993) Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res Vet Sci 54:299–305 · DOI
  25. Heldens JG, Hannant D, Cullinane AA, Prendergast MJ, Mumford JA, Nelly M, Kydd JH, Weststrate MW, van den Hoven R (2001) Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 19:4307–17 · DOI
  26. Kim SK, Jang HK, Albrecht RA, Derbigny WA, Zhang Y, O’Callaghan DJ (2003) Interaction of the equine herpesvirus 1 EICP0 protein with the immediate-early (IE) protein, TFIIB, and TBP may mediate the antagonism between the IE and EICP0 proteins. J Virol 77:2675–85 · DOI
  27. Koppers-Lalic D, Verweij MC, Lipinska AD, Wang Y, Quinten E, Reits EA, Koch J, Loch S, Marcondes Rezende M, Daus F, Bienkowska-Szewczyk K, Osterrieder N, Mettenleiter TC, Heemskerk MH, Tampe R, Neefjes JJ, Chowdhury SI, Ressing ME, Rijsewijk FA, Wiertz EJ (2008) Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP. PLoS Pathog 4:e1000080 · DOI · Paper page
  28. Kotturi M, Peters B, Buendia-Laysa F, Sidney J, Oseroff C, Botten J, Grey H, Buchmeier M, Sette A (2007) The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J Virol 81:4928–4940 · DOI · Paper page
  29. Kydd JH, Davis-Poynter NJ, Birch J, Hannant D, Minke J, Audonnet JC, Antczak DF, Ellis SA (2006) A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1. J Gen Virol 87:2507–15 · DOI
  30. Kydd JH, Wattrang E, Hannant D (2003) Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet Immunol Immunopathol 96:207–17 · DOI
  31. Lanier LL (1997) Natural killer cell receptors and MHC class I interactions. Curr Opin Immunol 9:126–31 · DOI
  32. Lauemoller SL, Holm A, Hilden J, Brunak S, Holst Nissen M, Stryhn A, Ostergaard Pedersen L, Buus S (2001) Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations. Tissue Antigens 57:405–14 · doi:10.1034/j.1399-0039.2001.057005405.x
  33. Lazary S, Antczak DF, Bailey E, Bell TK, Bernoco D, Byrns G, McClure JJ (1988) Joint Report of the Fifth International Workshop on Lymphocyte alloantigens of the horse, Baton Rouge, Louisiana, 31 October–1 November 1987. Anim Genet 19:447–56 · doi:10.1111/j.1365-2052.1988.tb00836.x
  34. Loffredo JT, Sidney J, Bean AT, Beal DR, Bardet W, Wahl A, Hawkins OE, Piaskowski S, Wilson NA, Hildebrand WH, Watkins DI, Sette A (2009) Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol 182:7763–75 · DOI
  35. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, Worning P, Sylvester-Hvid C, Lamberth K, Roder G, Justesen S, Buus S, Brunak S (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55:797–810 · DOI · Paper page
  36. Ma G, Azab W, Osterrieder N (2013) Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)—masters of co-evolution and a constant threat to equids and beyond. Vet Microbiol 167:123–34 · DOI
  37. McGuire TC, Leib SR, Mealey RH, Fraser DG, Prieur DJ (2003) Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule. J Immunol 171:1984–93 · doi:10.4049/jimmunol.171.4.1984
  38. Mealey RH, Lee JH, Leib SR, Littke MH, McGuire TC (2006) A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL. J Immunol 177:7377–90 · DOI
  39. Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823–36 · DOI · Paper page
  40. Ostlund EN (1993) The equine herpesviruses. Vet Clin North Am Equine Pract 9:283–94 · DOI
  41. Paillot R, Ellis SA, Daly JM, Audonnet JC, Minke JM, Davis-Poynter N, Hannant D, Kydd JH (2006) Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 24:1490–500 · DOI
  42. Patel JR, Heldens J (2005) Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)—epidemiology, disease and immunoprophylaxis: a brief review. Vet J 170:14–23 · DOI · Paper page
  43. Paul S, Weiskopf D, Angelo MA, Sidney J, Peters B, Sette A (2013) HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. J Immunol 191:5831–9 · DOI · Paper page
  44. Peters B, Bui H-H, Frankild S, Nielsen M, Lundegaard C, Kostem E, Basch D, Lamberth K, Harndahl M, Fleri W, Wilson SS, Sidney J, Lund O, Buus S, Sette A (2006) A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2:e65 · DOI · Paper page
  45. Pinilla C, Appel JR, Blanc P, Houghten RA (1992) Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. Biotechniques 13:901–5
  46. Rappocciolo G, Birch J, Ellis SA (2003) Down-regulation of MHC class I expression by equine herpesvirus-1. J Gen Virol 84:293–300 · DOI · Paper page
  47. Reed JS, Sidney J, Piaskowski SM, Glidden CE, Leon EJ, Burwitz BJ, Kolar HL, Eernisse CM, Furlott JR, Maness NJ, Walsh AD, Rudersdorf RA, Bardet W, McMurtrey CP, O’Connor DH, Hildebrand WH, Sette A, Watkins DI, Wilson NA (2011) The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection. Immunogenetics 63:789–807 · DOI
  48. Rosas CT, Goodman LB, von Einem J, Osterrieder N (2006) Equine herpesvirus type 1 modified live virus vaccines: quo vaditis? Exp Rev Vaccines 5:119–31 · DOI
  49. Rotzschke O, Falk K (1991) Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. Immunol Today 12:447–55 · doi:10.1016/0167-5699(91)90018-o
  50. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A (1993) Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929–37 · DOI · Paper page
  51. Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 219:277–319 · DOI · Paper page
  52. Serwold T, Gaw S, Shastri N (2001) ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat Immunol 2:644–51 · DOI · Paper page
  53. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J et al (1994) The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153:5586–92 · DOI · Paper page
  54. Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A, Peters B (2008a) Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 4:2 · DOI · Paper page
  55. Sidney J, Peters B, Moore C, Pencille TJ, Ngo S, Masterman KA, Asabe S, Pinilla C, Chisari FV, Sette A (2007) Characterization of the peptide-binding specificity of the chimpanzee class I alleles A*0301 and A*0401 using a combinatorial peptide library. Immunogenetics 59:745−751 · doi:10.1007/s00251-007-0243-5
  56. Sidney J, Southwood S, Moore C, Oseroff C, Pinilla C, Grey HM, Sette A (2013) Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture. Curr Protoc Immunol Chapter 18:Unit 18 3 · DOI · Paper page
  57. Slingluff CL Jr, Cox AL, Henderson RA, Hunt DF, Engelhard VH (1993) Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J Immunol 150:2955–63 · DOI
  58. Soboll G, Breathnach CC, Kydd JH, Hussey SB, Mealey RM, Lunn DP (2010) Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease. Vet Immunol Immunopathol 135:108–17 · DOI
  59. Soboll G, Whalley JM, Koen MT, Allen GP, Fraser DG, Macklin MD, Swain WF, Lunn DP (2003) Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes. J Gen Virol 84:2625–34 · DOI
  60. Southwood S, Solomon C, Hoof I, Rudersdorf R, Sidney J, Peters B, Wahl A, Hawkins O, Hildebrand W, Mothe BR, Sette A (2011) Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities. Immunogenetics 63:275–290 · DOI
  61. Spurgin LG, Richardson DS (2010) How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc Biol Sci 277:979–88 · DOI · Paper page
  62. Stryhn A, Pedersen LO, Romme T, Holm CB, Holm A, Buus S (1996) Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding. Eur J Immunol 26:1911–8 · DOI
  63. Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240:1285–93 · DOI · Paper page
  64. Tallmadge RL, Campbell JA, Miller DC, Antczak DF (2010) Analysis of MHC class I genes across horse MHC haplotypes. Immunogenetics 62:159–72 · DOI
  65. Tallmadge RL, Lear TL, Antczak DF (2005) Genomic characterization of MHC class I genes of the horse. Immunogenetics 57:763–74 · DOI
  66. Trolle T, Metushi IG, Greenbaum JA, Kim Y, Sidney J, Lund O, Sette A, Peters B, Nielsen M (2015) Automated benchmarking of peptide-MHC class I binding predictions. Bioinformatics · DOI
  67. Tseng CT, Miller D, Cassano J, Bailey E, Antczak DF (2010) Identification of equine major histocompatibility complex haplotypes using polymorphic microsatellites. Anim Genet 41(Suppl 2):150–3 · DOI
  68. Udaka K, Wiesmuller KH, Kienle S, Jung G, Tamamura H, Yamagishi H, Okumura K, Walden P, Suto T, Kawasaki T (2000) An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 51:816–28 · DOI
  69. Udaka K, Wiesmuller KH, Kienle S, Jung G, Walden P (1995) Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J Exp Med 181:2097–108 · DOI
  70. Udeshi ND, Compton PD, Shabanowitz J, Hunt DF, Rose KL (2008) Methods for analyzing peptides and proteins on a chromatographic timescale by electron-transfer dissociation mass spectrometry. Nat Protoc 3:1709–17 · DOI
  71. Vaiman M, Chardon P, Cohen D (1986) DNA polymorphism in the major histocompatibility complex of man and various farm animals. Anim Genet 17:113–33 · DOI
  72. Van de Walle GR, Goupil R, Wishon C, Damiani A, Perkins GA, Osterrieder N (2009) A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease. J Infect Dis 200:20–5 · DOI · Paper page
  73. Wang P, Sidney J, Dow C, Mothe B, Sette A, Peters B (2008) A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 4:e1000048 · DOI · Paper page
  74. Weiskopf D, Yauch LE, Angelo MA, John DV, Greenbaum JA, Sidney J, Kolla RV, De Silva AD, de Silva AM, Grey H, Peters B, Shresta S, Sette A (2011) Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J Immunol 187:4268–79 · DOI
  75. Zhang W, Lonning SM, McGuire TC (1998) Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J Virol 72:9612–20 · doi:10.1128/jvi.72.12.9612-9620.1998
  76. Zhao Y, Holden VR, Smith RH, O’Callaghan DJ (1995) Regulatory function of the equine herpesvirus 1 ICP27 gene product. J Virol 69:2786–93 · doi:10.1128/jvi.69.5.2786-2793.1995

Cited by

See all 7

Metadata

Authors
Bergmann, T., Moore, C., Sidney, J., Miller, D., Tallmadge, R., Harman, R. M., Oseroff, C., Wriston, A., Shabanowitz, J., Hunt, D. F., Osterrieder, N., Peters, B., Antczak, D. F., & Sette, A.
Venue
Immunogenetics
Published
2015-09-23
Volume
67
Issue
11-12
Pages
675-689
ISSN
  • 0093-7711
  • 1432-1211
Cited by
7
References
4
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.